Vitamin B12 Deficiency in Dogs (Cobalamin Malabsorption)
- Occurrence: rarer
- Location of disease: Abdomen/pelvis
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
Cobalamin malabsorption in dogs is a condition where the body is unable to efficiently absorb Vitamin B12 (cobalamin) from food, leading to a deficiency of this essential nutrient.
Das Wichtigste auf einen Blick
Vitamin B12, also called cobalamin, is crucial for canine metabolism, especially for the formation of red blood cells and the function of the nervous system. Dogs absorb B12 in the small intestine after it binds to Intrinsic Factor (IF). Disruptions in this process lead to cobalamin malabsorption. Genetic defects, particularly in breeds like Border Collies, Beagles, and Giant Schnauzers, can impair the formation or function of IF or receptors in the small intestine. Other causes include inflammatory bowel diseases or exocrine pancreatic insufficiency. Symptoms include anemia, Weight loss, and Muscle weakness. Diagnosis relies on blood tests that can reveal low B12 levels and signs of anemia. Further tests such as the TLI test or endoscopy may be necessary. Treatment usually involves B12 injections to correct the deficiency. For genetic causes, lifelong treatment is necessary. The prognosis is good if treatment is timely, with quality of life maintained through appropriate therapy. Prevention is difficult, but genetic tests can help reduce the risk in breeding. Research focuses on genetic causes and improving diagnostic and treatment methods to enable a better quality of life for affected dogs.
Ursachen
Vitamin B12, also known as cobalamin, is a water-soluble vitamin that plays a crucial role in metabolism, particularly in the formation of red blood cells and the function of the nervous system. The body cannot produce cobalamin itself, which is why it must be absorbed through food. In dogs, Vitamin B12 is primarily absorbed in the last section of the small intestine, the ileum.
For Vitamin B12 to be absorbed from food, it must first bind in the stomach to a protein called Intrinsic Factor (IF), which is produced by the pancreas. This complex of Vitamin B12 and Intrinsic Factor then travels to the small intestine, where it binds to specific receptors and is absorbed. Disruptions in this process can lead to insufficient absorption.
The most common causes of cobalamin malabsorption in dogs are genetic defects that impair the formation or function of the Intrinsic Factor or the receptors in the small intestine. Specifically, breeds such as the Border Collie, Beagle, and Giant Schnauzer are genetically predisposed. Other causes can include inflammatory bowel diseases, exocrine pancreatic insufficiency, or bacterial overgrowth in the small intestine.
A genetic defect can lead to the Intrinsic Factor either not being formed at all or in insufficient quantities. Similarly, the receptors in the small intestine could be defective or missing, which prevents the binding and absorption of Vitamin B12. Otherwise, inflammatory processes can severely damage the small intestinal mucosa, reducing the intestine’s absorptive capacity.
Symptoms
Symptoms of cobalamin deficiency in dogs can vary and are often non-specific, which can make diagnosis difficult. Common signs include general weakness and Lethargy. Dogs with this condition often appear tired and have low energy, which can manifest as reduced interest in exercise and play.
Other common symptoms include loss of appetite and Weight loss. Since Vitamin B12 plays an important role in metabolism, dogs with a deficiency may have difficulty properly digesting and utilizing food, which can lead to Weight loss despite normal or even increased food intake.
Gastrointestinal symptoms are also common and can include Diarrhea or Vomiting. These symptoms occur because a lack of Vitamin B12 disrupts the normal function of the digestive system. In some cases, neurological symptoms such as Balance disorders or Behavioral changes may also occur, as Vitamin B12 is crucial for nervous system health.
Diagnose
The diagnosis of cobalamin malabsorption in dogs usually begins with a thorough clinical examination and a detailed medical history to identify possible symptoms and risk factors. However, due to non-specific symptoms, it can be difficult to make a clear diagnosis based on medical history alone.
Blood tests are an essential part of the diagnosis. A low Vitamin B12 level in the blood serum is a direct indicator of a deficiency. Furthermore, blood tests can indicate signs of anemia or other changes associated with Vitamin B12 deficiency.
In some cases, further tests may be required to determine the exact cause of malabsorption. These may include tests to check pancreatic function, such as the Trypsin-like Immunoreactivity (TLI) test, to rule out exocrine pancreatic insufficiency. An examination for bacterial overgrowth of the small intestine or an endoscopy to assess the intestine could also be considered.
Therapie
The therapy for cobalamin malabsorption aims to restore Vitamin B12 levels in the body and treat the underlying cause of the malabsorption. The most common and effective method for treating Vitamin B12 deficiency is the direct administration of Vitamin B12, usually in the form of injections. These bypass the digestive tract and ensure that the vitamin enters the bloodstream directly.
Initially, weekly injections are usually administered until the Vitamin B12 level is normalized. Subsequently, injections can be continued at a longer interval, such as monthly, to maintain the level. In some cases, oral Vitamin B12 preparations may also be used, although their effectiveness in dogs with malabsorption problems can vary.
If an underlying condition such as exocrine pancreatic insufficiency or inflammatory bowel disease is identified, it must also be treated accordingly. Treatment may include enzyme replacement therapies, special diets, or anti-inflammatory medications.
Prognose und Nachsorge
The prognosis for dogs with cobalamin malabsorption largely depends on the underlying cause, as well as timely diagnosis and treatment. In many cases, adequate Vitamin B12 supplementation therapy can completely alleviate symptoms and restore normal quality of life.
For genetic causes, lifelong administration of Vitamin B12 is necessary, but most affected dogs respond well to treatment. The prognosis is generally good, provided there are no other serious health problems.
For dogs with an underlying condition such as exocrine pancreatic insufficiency or inflammatory bowel disease, the prognosis depends on the severity of the disease and the response to therapy. Close collaboration with the veterinarian is crucial to adjust the therapy and monitor the dog’s health.
Prävention
Since genetic factors play a significant role in cobalamin malabsorption, it is difficult to completely prevent the disease. One possibility for prevention is to consider genetic predisposition in breeding. Responsible breeding practices that include genetic tests for predispositions to this disease can help reduce the risk in certain breeds.
For dogs that already have a predisposition or have been diagnosed with cobalamin malabsorption, close monitoring and regular veterinary check-ups are important to keep an eye on Vitamin B12 levels. A balanced diet that meets the dog’s nutritional needs can also contribute to general health prevention.
Although direct prevention is difficult, early detection and treatment can prevent serious health consequences. Owners should pay attention to the described symptoms and seek veterinary advice immediately if Vitamin B12 deficiency is suspected.
Ausblick auf aktuelle Forschung
Cobalamin malabsorption in dogs is a genetic disorder that impairs the dog’s ability to absorb Vitamin B12 (cobalamin) from food. This disease often occurs in certain breeds such as the Border Collie, Beagle, and Giant Schnauzer. Current research focuses on the genetic causes of this disease and the development of new diagnostic and treatment methods.
A significant advance in research is the identification of specific genetic mutations that lead to this malabsorption. Scientists use modern genetic sequencing techniques to identify the genes responsible for proper Vitamin B12 absorption. These findings help veterinarians develop genetic tests that enable early diagnosis before symptoms become severe.
Another area of research focuses on improving therapeutic approaches. Researchers are currently investigating the effectiveness of various forms of Vitamin B12 supplementation, including oral and injectable preparations. The goal is to find the most suitable therapy that effectively increases cobalamin levels in the blood of affected dogs and alleviates the symptoms of the disease.
Work is also underway on the development of dietary supplements specifically formulated to improve Vitamin B12 absorption. Some studies have shown that certain probiotic preparations can support digestive system health and improve nutrient absorption, including cobalamin absorption.
Long-term studies are underway to investigate the effects of early diagnosis and treatment on the quality of life and life expectancy of affected dogs. These studies are crucial to assess how effective current treatment methods are and whether there are better alternatives.
A promising area of research is also the investigation of environmental and nutritional factors that could influence Vitamin B12 absorption. Researchers are trying to understand how diet and lifestyle can increase or decrease the risk of developing this disease, which could lead to preventive measures.
In summary, research into cobalamin malabsorption in dogs aims to understand the genetic basis of the disease, improve diagnosis, and develop more effective treatment strategies. With continuous progress in research, there is hope for a better quality of life and prognosis for affected dogs.
Frequently Asked Questions (FAQs)
1. What is cobalamin malabsorption in dogs?
2. Which breeds are most commonly affected?
3. What Symptoms occur in affected dogs?
4. How is the disease diagnosed?
5. How is cobalamin malabsorption treated?
6. Can affected dogs lead a normal life?
7. Are there prevention options for cobalamin malabsorption?
8. Are dietary supplements necessary for affected dogs?
9. How often should affected dogs be monitored by a veterinarian?
10. What are the long-term effects of the disease on dogs?
Literatur
- Kather, S., Grützner, N., Kook, P. H., Dengler, F., Heilmann, R. M., & Suchodolski, J. S. (2019). Review of cobalamin status and disorders of cobalamin metabolism in dogs. Journal of Veterinary Internal Medicine, 33(1), 13–28. https://doi.org/10.1111/jvim.15347
- Fyfe, J. C., Hemker, S. L., Venta, P. J., Stebbing, B., Giger, U., & Henthorn, P. S. (2014). Selective intestinal cobalamin malabsorption with proteinuria in Beagles. Journal of Veterinary Internal Medicine, 28(2), 356–362. https://doi.org/10.1111/jvim.12268
- Owczarek-Lipska, M., Jagannathan, V., Drögemüller, C., & Leeb, T. (2013). A frameshift mutation in the cubilin gene (CUBN) in Border Collies with Imerslund-Gräsbeck syndrome (selective cobalamin malabsorption). PLOS ONE, 8(4), Article e61144. https://doi.org/10.1371/journal.pone.0061144
- Drögemüller, M., Jagannathan, V., Howard, J., Bruggmann, R., Drögemüller, C., Ruetten, M., & Leeb, T. (2014). A frameshift mutation in the cubilin gene (CUBN) in Beagles with Imerslund-Gräsbeck syndrome (selective cobalamin malabsorption). Animal Genetics, 45(1), 148–150. https://doi.org/10.1111/age.12094
- He, Q., Madsen, M., Kilkenney, A., Gregory, B., Christensen, E. I., Vorum, H., Højrup, P., Schäffer, A. A., Kirkness, E. F., & Giger, U. (2003). Canine Imerslund-Gräsbeck syndrome maps to a region orthologous to human IGS on HSA14. Mammalian Genome, 14(11), 758–764. https://doi.org/10.1007/s00335-003-2280-1
- Bishop, M. A., Xenoulis, P. G., Berghoff, N., Grützner, N., Suchodolski, J. S., & Steiner, J. M. (2012). Partial characterization of cobalamin deficiency in Chinese Shar Peis. The Veterinary Journal, 191(1), 41–45. https://doi.org/10.1016/j.tvjl.2011.05.004
- Toresson, L., Steiner, J. M., Olmedal, G., & Suchodolski, J. S. (2016). Oral cobalamin supplementation in dogs with chronic enteropathies and hypocobalaminemia. Journal of Veterinary Internal Medicine, 30(1), 101–107. https://doi.org/10.1111/jvim.13823
- Hanisch, F., Toresson, L., & Spillmann, T. (2018). Cobalaminmangel bei Hund und Katze. Tierärztliche Praxis Ausgabe K: Kleintiere/Heimtiere, 46(5), 309–314. https://doi.org/10.15654/TPK-180458
- Kather, S., Grützner, N., Kook, P. H., Dengler, F., Heilmann, R. M., & Suchodolski, J. S. (2019). Review of cobalamin status and disorders of cobalamin metabolism in dogs. Journal of Veterinary Internal Medicine, 33(1), 13–28. https://doi.org/10.1111/jvim.15347
- Fyfe, J. C., Hemker, S. L., Venta, P. J., Stebbing, B., Giger, U., & Henthorn, P. S. (2014). Selective intestinal cobalamin malabsorption with proteinuria in Beagles. Journal of Veterinary Internal Medicine, 28(2), 356–362. https://doi.org/10.1111/jvim.12268
- Owczarek-Lipska, M., Jagannathan, V., Drögemüller, C., & Leeb, T. (2013). A frameshift mutation in the cubilin gene (CUBN) in Border Collies with Imerslund-Gräsbeck syndrome (selective cobalamin malabsorption). PLOS ONE, 8(4), Article e61144. https://doi.org/10.1371/journal.pone.0061144
- Drögemüller, M., Jagannathan, V., Howard, J., Bruggmann, R., Drögemüller, C., Ruetten, M., & Leeb, T. (2014). A frameshift mutation in the cubilin gene (CUBN) in Beagles with Imerslund-Gräsbeck syndrome (selective cobalamin malabsorption). Animal Genetics, 45(1), 148–150. https://doi.org/10.1111/age.12094
- He, Q., Madsen, M., Kilkenney, A., Gregory, B., Christensen, E. I., Vorum, H., Højrup, P., Schäffer, A. A., Kirkness, E. F., & Giger, U. (2003). Canine Imerslund-Gräsbeck syndrome maps to a region orthologous to human IGS on HSA14. Mammalian Genome, 14(11), 758–764. https://doi.org/10.1007/s00335-003-2280-1
- Bishop, M. A., Xenoulis, P. G., Berghoff, N., Grützner, N., Suchodolski, J. S., & Steiner, J. M. (2012). Partial characterization of cobalamin deficiency in Chinese Shar Peis. The Veterinary Journal, 191(1), 41–45. https://doi.org/10.1016/j.tvjl.2011.05.004
- Toresson, L., Steiner, J. M., Olmedal, G., & Suchodolski, J. S. (2016). Oral cobalamin supplementation in dogs with chronic enteropathies and hypocobalaminemia. Journal of Veterinary Internal Medicine, 30(1), 101–107. https://doi.org/10.1111/jvim.13823
- Hanisch, F., Toresson, L., & Spillmann, T. (2018). Cobalaminmangel bei Hund und Katze. Tierärztliche Praxis Ausgabe K: Kleintiere/Heimtiere, 46(5), 309–314. https://doi.org/10.15654/TPK-180458